See all locations for this study
Phase 1Recruiting

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Sponsored by Obsidian Therapeutics, Inc.

About this study

This is a study to investigate the safety and efficacy of an investigational OBX-115 regimen in adult participants with advanced solid tumors.

Enrolling at this location

James Graham Brown Cancer Center (Melanoma/NSCLC)

Louisville, Kentucky

I'm interested

This study also enrolls at 8 other locations. See all.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.